Explore our complete collection of peptide guides, research, and wellness insights
As Medicare expands semaglutide coverage for weight loss, researchers investigate whether AOD-9604 could help preserve muscle mass during GLP-1
Read More →New data link semaglutide to increased fracture risk in menopausal women. This article examines whether AOD-9604, a peptide fragment of growth
Read More →GLP-1 agonists like semaglutide accelerate weight loss but may increase bone density decline in menopausal women, raising fracture risk. Research g...
Read More →The ACP's new obesity guidelines endorse GLP-1 agonists but leave muscle-loss risk unaddressed. AOD-9604 research suggests a fat-selective mechanis...
Read More →Les agonistes GLP-1 comme le semaglutide induisent une perte de poids substantielle, mais 25-40 % provient de la masse maigre — l'AOD-9604 pourrait...
Read More →
